STA Provision of Investigational Medicinal Product (IMP) and placebo
AwardHighlights
- Award value
- £152,440
- Winning supplier
- Liverpool University Hospital NHS FT - Trading as MIAA
- Award date
- —
Details
- Published
- 23 Oct 2026
- Deadline
- —
- Value
- £152,440
- Location
- —
- Source
- Find a Tender
- Source notice ID
- 100701-2026
- OCID
- ocds-h6vhtk-078f7f
- CPV codes
- —
Description
IMP/placebo formulation type it needs to be manufactured in aseptic conditions. This requires a highly specialised manufacturing process and as a result UK Manufacturers of Aseptic servicesable to offer this srvice is are limited. During the grant (funding) application stage 5 other NHS pharmacy aseptic services were approached to provided a quote for the service - all of which were unable to provide the service to the required specifications.
More from Bristol NHS Foundation Trust
View all- SWAG Cancer Alliance Lung Cancer Screening ProgrammeTenderBristol NHS Foundation Trust—
- SWAG Cancer Alliance Lung Cancer Screening ProgrammeTenderBristol NHS Foundation TrustCloses 4 Dec 2026
- Somerset, Wiltshire, Avon, and Gloucestershire Cancer Alliance Lung Cancer Screening Managed ServicePipelineBristol NHS Foundation Trust—
- Somerset, Wiltshire, Avon, and Gloucestershire Cancer Alliance Lung Cancer Screening Managed ServicePlanningBristol NHS Foundation Trust—
- ECGs RRPContractBristol NHS Foundation TrustAwarded
Lots (1)
| Lot | Title | Value |
|---|---|---|
| 1 | Lot 1 | — |
Awarded contracts (1)
| Title | Supplier | Value | Awarded |
|---|---|---|---|
| Award 1 | Liverpool University Hospital NHS FT - Trading as MIAA | £152,440 | — |